Evolus Financial Statements From 2010 to 2025
| EOLS Stock | USD 10.51 0.10 0.94% |
Check Evolus financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Evolus' main balance sheet or income statement drivers, such as , as well as many indicators such as . Evolus financial statements analysis is a perfect complement when working with Evolus Valuation or Volatility modules.
Evolus |
Evolus Inc Company Operating Margin Analysis
Evolus' Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Evolus Operating Margin | (0.21) % |
Most of Evolus' fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Evolus Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, Evolus Inc has an Operating Margin of -0.2136%. This is 99.39% lower than that of the Pharmaceuticals sector and significantly lower than that of the Health Care industry. The operating margin for all United States stocks is 96.12% lower than that of the firm.
Evolus Inc Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Evolus's current stock value. Our valuation model uses many indicators to compare Evolus value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Evolus competition to find correlations between indicators driving Evolus's intrinsic value. More Info.Evolus Inc is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Evolus by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.About Evolus Financial Statements
Evolus shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Evolus investors may analyze each financial statement separately, they are all interrelated. The changes in Evolus' assets and liabilities, for example, are also reflected in the revenues and expenses on on Evolus' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. The company was incorporated in 2012 and is headquartered in Newport Beach, California. Evolus operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 174 people.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Evolus Stock Analysis
When running Evolus' price analysis, check to measure Evolus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evolus is operating at the current time. Most of Evolus' value examination focuses on studying past and present price action to predict the probability of Evolus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evolus' price. Additionally, you may evaluate how the addition of Evolus to your portfolios can decrease your overall portfolio volatility.